These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 17013836

  • 1. Neoplastic hepatocyte growth associated with cyclin D1 redistribution from the cytoplasm to the nucleus in mouse hepatocarcinogenesis.
    Yamamoto M, Tamakawa S, Yoshie M, Yaginuma Y, Ogawa K.
    Mol Carcinog; 2006 Dec; 45(12):901-13. PubMed ID: 17013836
    [Abstract] [Full Text] [Related]

  • 2. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E.
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [Abstract] [Full Text] [Related]

  • 3. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I, Zhang H, Mizuta T, Ide Y, Eguchi Y, Yasutake T, Sakamaki T, Pestell RG, Yamamoto K.
    Clin Cancer Res; 2007 Apr 01; 13(7):2236-45. PubMed ID: 17404108
    [Abstract] [Full Text] [Related]

  • 4. Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway.
    Chen C, Chang YC, Liu CL, Liu TP, Chang KJ, Guo IC.
    Endocr Relat Cancer; 2007 Jun 01; 14(2):513-29. PubMed ID: 17639064
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of the Ras oncoprotein reduces proliferation of hepatocytes in vitro and in vivo in rats.
    da Silva Morais A, Saliez A, Leclercq I, Horsmans Y, Stärkel P.
    Clin Sci (Lond); 2008 Jan 01; 114(1):73-83. PubMed ID: 17678500
    [Abstract] [Full Text] [Related]

  • 6. L-leucine increases [3H]-thymidine incorporation in chicken hepatocytes: involvement of the PKC, PI3K/Akt, ERK1/2, and mTOR signaling pathways.
    Lee MY, Jo SD, Lee JH, Han HJ.
    J Cell Biochem; 2008 Dec 15; 105(6):1410-9. PubMed ID: 18980246
    [Abstract] [Full Text] [Related]

  • 7. Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1.
    Yang C, Klein EA, Assoian RK, Kazanietz MG.
    Biochem J; 2008 Feb 15; 410(1):167-75. PubMed ID: 17941827
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of cyclin D1 is associated with elevated levels of MAP kinases, Akt and Pak1 during diethylnitrosamine-induced progressive liver carcinogenesis.
    Parekh P, Rao KV.
    Cell Biol Int; 2007 Jan 15; 31(1):35-43. PubMed ID: 17055752
    [Abstract] [Full Text] [Related]

  • 9. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
    Xue WJ, Li C, Zhou XJ, Guan HG, Qin L, Li P, Wang ZW, Qian HX.
    J Gastroenterol Hepatol; 2008 Sep 15; 23(9):1448-58. PubMed ID: 17683489
    [Abstract] [Full Text] [Related]

  • 10. Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice.
    Katzenellenbogen M, Mizrahi L, Pappo O, Klopstock N, Olam D, Jacob-Hirsch J, Amariglio N, Rechavi G, Domany E, Galun E, Goldenberg D.
    Mol Cancer Res; 2007 Nov 15; 5(11):1159-70. PubMed ID: 18025261
    [Abstract] [Full Text] [Related]

  • 11. Tumor necrosis factor-alpha inhibits Schwann cell proliferation by up-regulating Src-suppressed protein kinase C substrate expression.
    Tao T, Ji Y, Cheng C, Yang H, Liu H, Sun L, Qin Y, Yang J, Wang H, Shen A.
    J Neurochem; 2009 Nov 15; 111(3):647-55. PubMed ID: 19694904
    [Abstract] [Full Text] [Related]

  • 12. [The role of different kinase pathways of signal transduction in proliferation of E1A + Ras transformants].
    Abramova MV, Svetlikova SB, Grinkevich VV, Pospelov VA.
    Tsitologiia; 2005 Nov 15; 47(12):1071-81. PubMed ID: 16706195
    [Abstract] [Full Text] [Related]

  • 13. Coordinated expression of cyclin D1 and LEF-1/TCF transcription factor is restricted to a subset of hepatocellular carcinoma.
    Schmitt-Graeff A, Ertelt-Heitzmann V, Allgaier HP, Olschewski M, Nitschke R, Haxelmans S, Koelble K, Behrens J, Blum HE.
    Liver Int; 2005 Aug 15; 25(4):839-47. PubMed ID: 15998435
    [Abstract] [Full Text] [Related]

  • 14. Expression of a cyclin E1 isoform in mice is correlated with the quiescent cell cycle status of hepatocytes in vivo.
    Zschemisch NH, Liedtke C, Dierssen U, Nevzorova YA, Wüstefeld T, Borlak J, Manns MP, Trautwein C.
    Hepatology; 2006 Jul 15; 44(1):164-73. PubMed ID: 16799991
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis B virus X induces cell proliferation in the hepatocarcinogenesis via up-regulation of cytoplasmic p21 expression.
    Yano M, Ohkoshi S, Aoki YH, Takahashi H, Kurita S, Yamazaki K, Suzuki K, Yamagiwa S, Sanpei A, Fujimaki S, Wakai T, Kudo SE, Matsuda Y, Aoyagi Y.
    Liver Int; 2013 Sep 15; 33(8):1218-29. PubMed ID: 23590292
    [Abstract] [Full Text] [Related]

  • 16. Aberrant cyclin A expression and centrosome overduplication induced by hepatitis B virus pre-S2 mutants and its implication in hepatocarcinogenesis.
    Wang LH, Huang W, Lai MD, Su IJ.
    Carcinogenesis; 2012 Feb 15; 33(2):466-72. PubMed ID: 22159224
    [Abstract] [Full Text] [Related]

  • 17. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation.
    Catalano S, Giordano C, Rizza P, Gu G, Barone I, Bonofiglio D, Giordano F, Malivindi R, Gaccione D, Lanzino M, De Amicis F, Andò S.
    J Cell Physiol; 2009 Mar 15; 218(3):490-500. PubMed ID: 18988190
    [Abstract] [Full Text] [Related]

  • 18. Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels.
    Baiz D, Pozzato G, Dapas B, Farra R, Scaggiante B, Grassi M, Uxa L, Giansante C, Zennaro C, Guarnieri G, Grassi G.
    Biochimie; 2009 Mar 15; 91(3):373-82. PubMed ID: 19041685
    [Abstract] [Full Text] [Related]

  • 19. Rapamycin disrupts cyclin/cyclin-dependent kinase/p21/proliferating cell nuclear antigen complexes and cyclin D1 reverses rapamycin action by stabilizing these complexes.
    Law M, Forrester E, Chytil A, Corsino P, Green G, Davis B, Rowe T, Law B.
    Cancer Res; 2006 Jan 15; 66(2):1070-80. PubMed ID: 16424043
    [Abstract] [Full Text] [Related]

  • 20. [Expression of cyclins in hepatocellular carcinoma and its correlation to tumor cell apoptosis].
    Peng SH, Yang JF, Xie PP, Deng H, Li H, Feng DY.
    Ai Zheng; 2005 Jun 15; 24(6):695-8. PubMed ID: 15946481
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.